Evidence map›Paper›PMID 36834992›Full record

ArticleInternational journal of molecular sciences2023

Discovery of New Heterocyclic/Benzofuran Hybrids as Potential Anti-Inflammatory Agents: Design, Synthesis, and Evaluation of the Inhibitory Activity of Their Related Inflammatory Factors Based on NF-κB and MAPK Signaling Pathways.

Yangling Chen, Rui Chen, Renyikun Yuan, Lini Huo, Hongwei Gao, Youqiong Zhuo, Xinxin Chen, Chenwei Zhang, Shilin Yang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yangling ChenCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Rui ChenCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Renyikun YuanCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Lini HuoCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Hongwei GaoCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Youqiong ZhuoCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Xinxin ChenCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Chenwei ZhangCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Shilin YangCollege of pharmacy, Guangxi University of Chinese Medicine, Nanning 530222, China.
Guangxi University · CNGuangxi University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NF-κB and MAPK are classic inflammation signaling pathways which regulate inflammation signal transmission and induce the expression of many inflammatory factors. Based on the potent anti-inflammatory activity of benzofuran and its derivatives, several new heterocyclic/benzofuran hybrids were first designed and synthesized by molecular hybridization. Their structure was confirmed by

Indexed as

Anti-Inflammatory AgentsBenzofuransMAP Kinase Signaling SystemNF-kappa BAnimalsHeterocyclic CompoundsInflammationInterleukin-6LipopolysaccharidesMiceRAW 264.7 CellsSignal TransductionTumor Necrosis Factor-alphaAnti-Inflammatory AgentsBenzofuransHeterocyclic CompoundsInterleukin-6LipopolysaccharidesNF-kappa BTumor Necrosis Factor-alphaanti-inflammatorybenzofuran derivativesendotoxemic miceNF-κB/MAPK signaling pathwaypiperazine

Identifiers

PMID36834992
PMCPMC9958778
OpenAlexW4319966485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.